Capecitabine and Oxaliplatin

DRUG7 trials

Conditions

Colorectal CancerGastric CancerGastric Cancer, Adjuvant Chemotherapy, XOLocally Advanced Colon CancerMetastatic Breast CancerMetastatic Colorectal Carcinoma (mCRC)

Phase 2

XELOX for Metastatic Breast Cancer

CompletedNCT00204776

University of Wisconsin, MadisonMetastatic Breast Cancer

Start: 2005-03-31End: 2006-11-30Target: 37Updated: 2019-12-12

Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

CompletedNCT00227734

Swiss Cancer InstituteColorectal Cancer

Start: 2004-06-30End: 2006-02-28Updated: 2012-06-05

Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer

SuspendedNCT00568529

Fudan UniversityGastric Cancer

Start: 2007-10-31End: 2010-02-28Target: 30Updated: 2010-05-26

Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and III

NCT01196260

State Key Laboratory of Cancer BiologyColorectal Cancer

Start: 2004-01-31End: 2020-12-31Target: 8000Updated: 2018-02-20

Analysis of the Effectiveness of Neoadjuvant Chemotherapy in the Treatment of Colon Cancer Locally Advanced (ELECLA)

NCT04188158

Universidad de LeónLocally Advanced Colon Cancer

Start: 2017-03-10End: 2024-03-10Target: 238Updated: 2019-12-05

Phase 3

Compare Adjuvant Chemotherapy of Docetaxel/Capecitabine/Oxliplatin Versus Capecitabine/Oxaliplatin in Advanced Gastric Cancer at Stage IIIb and IV(KCSG ST15-08): TRIUMPH

RecruitingNCT01935778

Asan Medical CenterGastric Cancer, Adjuvant Chemotherapy, XO

Start: 2013-10-02End: 2028-06-30Target: 286Updated: 2024-02-28

Unknown Phase

Comparison of Efficacy and Safety Between FOLFOX-6 and CAPOX in Metastatic Colorectal Carcinoma

Enrolling by invitationNCT07334587

Allama Iqbal Medical CollegeMetastatic Colorectal Carcinoma (mCRC)

Start: 2025-09-01End: 2026-02-28Target: 248Updated: 2026-01-12

Related Papers

The ELECLA trial: A multicentre randomised control trial on outcomes of neoadjuvant treatment on locally advanced colon cancer

Colorectal Disease2024-02-163 citations

A phase III study of adjuvant docetaxel, capecitabine and oxaliplatin triplet vs capecitabine and oxaliplatin doublet in patients with curatively resected stage IIIB or IV(M0) (AJCC 6th ed) gastric adenocarcinoma (TRIUMPH, KCSG ST14-05)